| Condition Brief | Condition Text | View |
|---|---|---|
| None | Psychotic Disorders | View |
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Weight Gain | View |
| None | Obesity | View |
| None | IMPACT | View |
| None | Antipsychotic Treatment | View |
| None | Excessive Weight Gain Associated With Antipsychotic Treatment | View |
| None | Hybrid Efficacy/Effectiveness Design | View |
| None | Reducing Weight Gain | View |
| None | Improving Metabolic Parameters | View |
| None | Aripiprazole | View |
| None | Metformin | View |
| None | Risperdal | View |
| None | Seroquel | View |
| None | Quetiapine | View |
| None | Olanzapine | View |
| None | Zyprexa | View |
| None | Geodon | View |
| None | Risperidone | View |
| None | Abilify | View |
| None | Trilafon | View |
| None | Perphenazine | View |
| None | Glucophage | View |
| None | Paliperidone | View |
| None | Olanzapine/fluoxetine | View |